#CCTG2023 Spring Meeting is almost here
Published:Category: Group updates
Request an invitation portal: closes April 17th
Online Registration: closes April 19th
- Pre-registering online will ensure a faster on-site registration process as your name tag will be ready for pick-up.
On-site Registration: Beat the Friday morning line-up and register on Thursday!!
CCTG Recruiting for a Patient Representative Volunteer Role
Published:Category: Group updates
Role Description
The Canadian Cancer Trials Group (CCTG) is currently seeking applications for a Patient Representative for the Gastro-Intestinal Disease Site Committee. CCTG is an inclusive organization dedicated to building a diverse network. We encourage applications from all qualified candidates and will accommodate applicants’ needs throughout all stages of the recruitment and selection process. Read More
CCTG Plenary Session
Published:Category: Group updates
The CCTG Plenary Session will be held at the Annual Spring Meeting of Participants on Friday April 28, 2023 from 4:30 – 5:30 pm in the Mountbatten room at the Chelsea Hotel in Toronto. The session will feature discussion on four outstanding clinical trials, CX1 (SHAPE) IND227 Phase II results, ENC1 a Phase III study, and the HE1 Phase III study. Read More
CCTG brain cancer trial awarded CCS Breakthrough Grant
Published:Category: News
Canadian Cancer Society announces details of research funding for low-survival cancers, the CCTG Breakthrough Grant Application lead by Dr Marshall Pitz, has received $ 1,549,130 over 5 years.
Read MoreNew Investigator Cancer Trials Practicum
Published:Category: News
A special congratulations to the next cohort for the 2023-2024 New Investigator Cancer Trials Practicum and on behalf of the entire CCTG network, we extend our congratulations to the 2022-2023 New Investigator Cancer Trials Practicum graduates. Read More
Publication: CO17|CO20 statistical
Published:Category: Publications
Bayesian approach for two-stage multivariate Mendelian randomization with mixed outcomes
Deng Y, Tu D, O'Callaghan CJ, Jonker DJ, Karapetis CS, Shapiro J, Liu G, Xu W. A Bayesian approach for two-stage multivariate Mendelian randomization with mixed outcomes (ONLINE).
Read MoreClosed to Accrual: CO29
Published:Category: Trials
The CO29 trial: Circulating Tumour DNA Analysis Informing Adjuvant Chemotherapy in Stage III Colon Cancer: A Multicentre Phase II/III Randomised Controlled Sutdy, AGITG DYNAMIC-III has closed to accrual. The study reached its overall accrual target of 1000 patients, 209 of which were randomized by Canadian sites.
Read MoreDeadline this week for the CCTG Award for Excellence in Clinical Trials Conduct
Published:Category: Group updates
The inaugural CCTG Award for Excellence in Clinical Trials Conduct will be presented this year at the Recognition Awards at the Annual Spring Meeting of Participants to an individual who exemplifies excellence in clinical trial operations and/or compliance at their institution.
Read More